We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




D-Dimer Test May Replace 60% of CT Lung Angiograms

By HospiMedica staff writers
Posted on 08 Jun 2004
The use of a D-dimer test as the first step in the diagnosis of blood clots in the lungs could eliminate the need for up to 60% of all computed tomography (CT) angiograms of the lungs, according to a new study by researchers at the Kaiser Foundation Hospital in Honolulu (HI, USA).

D-dimer tests measure the amount of D-dimer in a patient's blood. More...
D-dimer is a breakdown product of the protein fibrin, which is found in blood clots. People with an unusual amount of D-dimer in their blood presumably have blood clots somewhere in their body.

The study looked at 426 patients who underwent both CT angiography of the lungs and D-dimer level evaluation. A total of 84 of those patients had negative findings on D-dimer, 82 of whom also had negative findings on CT angiography. The remaining two had indeterminate findings on CT. Among patients with positive D-dimer tests, no one with a level between 0.4 and 1.0 µg/ml had positive findings for blood clots on CT angiography.

"In our retrospective analysis, we found that people who did not have an elevated amount of D-dimer in their body did not have blood clots in their lungs detected by CT, remarked Hyo-Chun Yoon, M.D., an author of the study. "In addition, we found that even people with an elevated D-dimer did not have blood clots in their lungs detected by CT if their level was abnormal but not very high, in our case 1.0 µg/ml. If we had used a cutoff value of 1.0 µg/ml, we may not have needed to do up to 60% of those CT angiograms. However, some of these patients may still have benefitted from a chest CT based on their presenting clinical situation.”

According to Dr. Yoon, the outcome of this study could have significant benefit to patients. "Although CT studies are helpful in the appropriate situation, they do expose patients to significant radiation, require the use of a contrast agent that can be toxic to the kidneys, and are quite expensive. We would like to see a prospective study done which confirms our findings before we firmly advocate anything, but I think the D-dimer will
significantly reduce the number of CT studies that are performed for blood clots in the lungs.”

This study appears in the June 2004 issue of the American Journal of Roentgenology.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.